Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep:83:102901.
doi: 10.1016/j.drugpo.2020.102901. Epub 2020 Aug 11.

No "back to normal" after COVID-19 for our failed drug policies

Affiliations

No "back to normal" after COVID-19 for our failed drug policies

Brandon Del Pozo et al. Int J Drug Policy. 2020 Sep.

Abstract

Before COVID-19 pandemic, advocates had long urged drug policy reforms based on health, security, civil rights, racial justice, fiscal stewardship, and other considerations. In the United States, such calls went largely unanswered. In response to COVID-19, public health and occupational safety concerns have rapidly transformed some drug policies, along with their enforcement. Almost contemporaneously, nationwide protests against violence and racism by militarized police have highlighted the enduring legacy of the Drug War in fueling carceral systems. Disruption from these historical events provides a once-in-a-century opportunity to reconsider the legal architecture of drug policy and policing-both in the U.S. and elsewhere. Rather than returning to a fundamentally broken and inequitable status quo, we urge envisioning a new drug policy in service to life, liberty, and the pursuit of happiness.

Keywords: COVID-19; Controlled Substances Act; Opioid use disorder; War on drugs.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interests Dr. del Pozo's work was supported by the National Institute on Drug Abuse (grant T32DA013911), and the National Institute of General Medical Science (grant P20GM125507). The institutes had no role in the preparation of this article, and the opinions expressed are the authors’ alone. Authors have no conflicts to disclose. No human subjects were involved, and no ethics approvals were required.

References

    1. Abraham A.J., Andrews C.M., Harris S.J., Friedmann P.D. Availability of medications for the treatment of alcohol and opioid use disorder in the USA. Neurotherapeutics : The Journal of the American Society for Experimental Neuro Therapeutics. 2020;17(1):55–69. doi: 10.1007/s13311-019-00814-4. - DOI - PMC - PubMed
    1. Ahrens D. Retroactive legality: Marijuana convictions and restoraitve justice in an era of criminal justice reform. Journal of Criminal Law & Criminology. 2020;110(3):379–440.
    1. Akiyama M.J., Spaulding A.C., Rich J.D. Flattening the curve for incarcerated populations — Covid-19 in jails and prisons. New England Journal of Medicine. 2020;382(22):2075–2077. doi: 10.1056/NEJMp2005687. - DOI - PMC - PubMed
    1. Alexander M. New Press; New York, N.Y: 2012. The new JIM crow: Mass incarceration in the age of colorblindness (Revised edition / with a new foreword by cornel west.. ed.)
    1. American Civil Liberties Union. (2020). A tale of two countries: Racially targeted arrests in the era of marijuana reform. Retrieved fromhttps://www.aclu.org/report/tale-two-countries-racially-targeted-arrests....

Publication types